The RADAR-CNS project aims to develop new ways of monitoring major depressive disorder, epilepsy, and multiple sclerosis using wearable devices and smartphone technology. The key goal of the project is to improve patients’ symptoms and quality of life and also to change how these and other chronic disorders are treated.
Among the latest achievements, the RADAR-CNS project has recruited the first participants to the multiple sclerosis (MS) component of the project. The participants will wear a Fitbit device for up to 24 hours a day. This will capture information about mobility, heart rate and sleep quality. Additionally, A research platform developed by IMI’s RADAR-CNS project has won a ‘Best of Show’ award in the data integration and management category at the Bio-IT World Conference & Expo in Boston, US in May. RADAR-CNS is working to develop new ways of measuring major depressive disorder, epilepsy and multiple sclerosis (MS) using wearable devices and smartphone technology.
Impact in international / European cooperation
This project aims to improve patients’ quality of life. We would like to support people and their healthcare team manage and treat their illness more effectively.
In the future, it might be possible to tell in advance if someone’s health has deteriorated by analysing the information collected from the wearable device and smartphone. However, more work will be needed before we reach that stage. The first step is to understand how well wearable devices and smartphones work for this purpose.